↓ Skip to main content

Phase I Study of Antisense Oligonucleotide Against Vascular Endothelial Growth Factor: Decrease in Plasma Vascular Endothelial Growth Factor With Potential Clinical Efficacy

Overview of attention for article published in Journal of Clinical Oncology, March 2006
Altmetric Badge

Mentioned by

patent
4 patents

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase I Study of Antisense Oligonucleotide Against Vascular Endothelial Growth Factor: Decrease in Plasma Vascular Endothelial Growth Factor With Potential Clinical Efficacy
Published in
Journal of Clinical Oncology, March 2006
DOI 10.1200/jco.2005.03.4801
Pubmed ID
Authors

Alexandra M. Levine, Anil Tulpule, David I. Quinn, Gerardo Gorospe, D. Lynne Smith, Laurie Hornor, William D. Boswell, Byron M. Espina, Susan G. Groshen, Rizwan Masood, Parkash S. Gill

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 29%
Student > Ph. D. Student 4 13%
Student > Master 4 13%
Lecturer 3 10%
Professor 2 6%
Other 6 19%
Unknown 3 10%
Readers by discipline Count As %
Medicine and Dentistry 16 52%
Agricultural and Biological Sciences 7 23%
Biochemistry, Genetics and Molecular Biology 1 3%
Sports and Recreations 1 3%
Computer Science 1 3%
Other 2 6%
Unknown 3 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2015.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from Journal of Clinical Oncology
#13,453
of 22,043 outputs
Outputs of similar age
#30,748
of 91,274 outputs
Outputs of similar age from Journal of Clinical Oncology
#71
of 120 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 91,274 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.